Evidence mapPaperPMID 40453585Full record

ArticleFrontiers in endocrinology2025

Fear of hypoglycemia is linked to poorer glycemic control and reduced quality of life in adults with type 1 diabetes.

Ángel Manuel Mesa Díaz, Samuel Belmonte Lomas, Pablo Rodríguez de Vera Gómez, María Victoria Llanes González, Carmen Mateo Rodríguez, Lucía Hidalgo Sotelo, María Asunción Martínez Brocca

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ángel Manuel Mesa DíazEndocrinology and Nutrition Department, Virgen Macarena University Hospital, Seville, Spain.
Samuel Belmonte LomasEndocrinology and Nutrition Department, Virgen Macarena University Hospital, Seville, Spain.
Pablo Rodríguez de Vera GómezEndocrinology and Nutrition Department, Virgen Macarena University Hospital, Seville, Spain.
María Victoria Llanes GonzálezEndocrinology and Nutrition Department, Virgen Macarena University Hospital, Seville, Spain.
Carmen Mateo RodríguezEndocrinology and Nutrition Department, Virgen Macarena University Hospital, Seville, Spain.
Lucía Hidalgo SoteloEndocrinology and Nutrition Department, Virgen Macarena University Hospital, Seville, Spain.
María Asunción Martínez BroccaEndocrinology and Nutrition Department, Virgen Macarena University Hospital, Seville, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Analyze the influence of Fear of Hypoglycemia (FoH) on quality of life and glycemic control in adults with Type 1 Diabetes Mellitus (T1D) who use Flash Glucose Monitoring (FGM). Methods: A cross-sectional study was conducted with 173 adults with T1D. FoH was assessed using the FH15 questionnaire, and quality of life was evaluated using the Spanish Diabetes Quality of Life questionnaire (EsDQOL). Glycemic control was analyzed through FGM-derived metrics (Ambulatory Glucose Profile) and HbA1c. Multivariate multiple linear regression models were developed to analyze the adjusted impact of FoH on quality of life and time in hyperglycemia. Results: FoH was present in 42% of participants (FH15 ≥28). Patients with FoH exhibited significantly higher EsDQOL scores, reflecting poorer quality of life, and higher HbA1c levels (7.41% vs. 7.08%, p=0.012). FGM metrics revealed higher mean glucose, glucose management indicator (GMI) (p=0.008), and time in hyperglycemia >250 mg/dL (p=0.035) in the FoH group, with lower time in range 70-180 mg/dl (p=0.035). Hypoglycemia unawareness was more frequent in the FoH group (25.4% vs. 6.5%, p=0.011). The FH15 score functioned as an independent predictor of quality of life (β = 1.98 [1.58; 2.37]) and time in hyperglycemia (β = 0.39 [0.17; 0.61]) in the multiple linear regression models. Conclusion: FoH is significantly associated with poor quality of life and worsened glycemic control in T1D patients, underscoring the need for systematic assessment and individualized interventions. FGM metrics, particularly time in hyperglycemia, may serve as valuable predictors of FoH. Comprehensive management strategies addressing both metabolic and psychological factors are essential for improving patient outcomes.

Indexed as

Diabetes Mellitus, Type 1FearGlycemic ControlHypoglycemiaQuality of LifeAdultBlood GlucoseBlood Glucose Self-MonitoringCross-Sectional StudiesFemaleGlycated HemoglobinHumansMaleMiddle AgedPrognosisSurveys and QuestionnairesBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanambulatory glucose profilefear of hypoglycemiaFH15 questionnaireflash glucose monitoringglycemic controlhypoglycemia unawarenessquality of lifetype 1 diabetes

Identifiers

PMID40453585
PMCPMC12122291

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.